Loading the security overview…
Where the tokens are
Trade ABCLWhat Abcellera Biologics has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Aug 13, 2026 | 8-K | Current report | On SEC.gov |
| Aug 10, 2026 | 8-K | Current report | On SEC.gov |
| Aug 7, 2026 | 8-K | Current report | On SEC.gov |
| Aug 5, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Aug 5, 2026 | 8-K | Current report | On SEC.gov |
| Jul 29, 2026 | 8-K | Current report | On SEC.gov |
| Jul 6, 2026 | 8-K | Current report | On SEC.gov |
| Jun 17, 2026 | 8-K | Current report | On SEC.gov |
| Jun 12, 2026 | 8-K | Current report | On SEC.gov |
| Jun 5, 2026 | 8-K | Current report | On SEC.gov |
| May 11, 2026 | 10-Q | Quarterly report | On SEC.gov |
| May 11, 2026 | 8-K | Current report | On SEC.gov |
| Feb 24, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 24, 2026 | 8-K | Current report | On SEC.gov |
| Jan 14, 2026 | 8-K | Current report | On SEC.gov |
| Dec 18, 2025 | 8-K | Current report | On SEC.gov |
| Nov 28, 2025 | 8-K | Current report | On SEC.gov |
| Nov 12, 2025 | 8-K | Current report | On SEC.gov |
| Nov 6, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Nov 6, 2025 | 8-K | Current report | On SEC.gov |
| Sep 10, 2025 | 8-K | Current report | On SEC.gov |
| Aug 7, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Aug 7, 2025 | 8-K | Current report | On SEC.gov |
| Jun 13, 2025 | 8-K | Current report | On SEC.gov |
| May 30, 2025 | 8-K | Current report | On SEC.gov |
| May 14, 2025 | 8-K | Current report | On SEC.gov |
| May 13, 2025 | 8-K | Current report | On SEC.gov |
| May 8, 2025 | 10-Q | Quarterly report | On SEC.gov |
| May 8, 2025 | 8-K | Current report | On SEC.gov |
| Feb 27, 2025 | 10-K | Annual report | On SEC.gov |
| Feb 27, 2025 | 8-K | Current report | On SEC.gov |
| Feb 18, 2025 | 8-K | Current report | On SEC.gov |
| Nov 4, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Nov 4, 2024 | 8-K | Current report | On SEC.gov |
| Aug 6, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Aug 6, 2024 | 8-K | Current report | On SEC.gov |
| Jun 13, 2024 | 8-K | Current report | On SEC.gov |
| May 7, 2024 | 10-Q | Quarterly report | On SEC.gov |
| May 7, 2024 | 8-K | Current report | On SEC.gov |
| Feb 23, 2024 | 8-K | Current report | On SEC.gov |
| Feb 20, 2024 | 10-K | Annual report | On SEC.gov |
| Feb 20, 2024 | 8-K | Current report | On SEC.gov |
| Nov 28, 2023 | 8-K | Current report | On SEC.gov |
| Nov 2, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Nov 2, 2023 | 8-K | Current report | On SEC.gov |
| Oct 13, 2023 | 8-K | Current report | On SEC.gov |
| Aug 3, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Aug 3, 2023 | 8-K | Current report | On SEC.gov |
| Jun 20, 2023 | 8-K | Current report | On SEC.gov |
| May 24, 2023 | 8-K | Current report | On SEC.gov |
| May 4, 2023 | 10-Q | Quarterly report | On SEC.gov |
| May 4, 2023 | 8-K | Current report | On SEC.gov |
| Mar 13, 2023 | 8-K | Current report | On SEC.gov |
| Feb 21, 2023 | 10-K | Annual report | On SEC.gov |
| Feb 21, 2023 | 8-K | Current report | On SEC.gov |
| Nov 8, 2022 | 10-Q | Quarterly report | On SEC.gov |
| Nov 8, 2022 | 8-K | Current report | On SEC.gov |
| Aug 9, 2022 | 10-Q | Quarterly report | On SEC.gov |
| Aug 9, 2022 | 8-K | Current report | On SEC.gov |
| Jul 19, 2022 | 8-K | Current report | On SEC.gov |
Figures describe Abcellera Biologics shares, not any token. As of Aug 24, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.